eXoZymes Inc. (EXOZ)

eXoZymes Inc. is a development-stage synthetic biology company that designs cell-free enzyme systems for biomanufacturing. Instead of engineering living microorganisms to produce chemicals, the company assembles modules of enzymes that operate outside cells, an approach it calls exozymes, to convert simple feedstocks into higher-value molecules.

The company aims to use this platform to produce compounds for markets such as pharmaceuticals, specialty chemicals and sustainable fuels and materials, and it works with partners to develop specific products and processes.

The company was incorporated in 2014 and operated as Invizyne Technologies until it changed its name to eXoZymes in 2025. It is headquartered in Monrovia, California, and its common stock trades on the Nasdaq Stock Market under the ticker EXOZ.